News Agency
Men's Weekly

Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study

  • Written by PR Newswire
Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study
  • ATN-031 (also known as ATG-031), is the first anti-CD24 antibody to advance to the clinic in oncology in the United States
  • The Phase I PERFORM trial, ongoing at four major U.S. cancer centers, is evaluating the safety and preliminary efficacy of ATN-031 in patients with advanced solid tumors or B-cell non-Hodgkin's lymphoma (B-NHL)

DOYLESTOWN, Pa., M...

Read more: Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study

Understanding SEO Services and Their Role in Business Growth

Boost your website’s visibility and attract the right audience with professional SEO services! Improve traffic, engagement, and results for your business.  Search engine optimisation services, widely known as SEO services, focus on improving how a website appears in search engine results... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion